Applied DNA Sciences Announces 1:20 Reverse Stock Split
TipRanks (Mon, 22-Apr 5:13 PM ET)
Applied DNA announces 1-for-20 reverse stock split
Seeking Alpha News (Mon, 22-Apr 4:23 PM ET)
Applied DNA Announces 1-For-20 Reverse Stock Split
ACCESSWIRE (Mon, 22-Apr 4:06 PM ET)
ACCESSWIRE (Thu, 14-Mar 10:01 AM ET)
Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results
ACCESSWIRE (Thu, 8-Feb 4:08 PM ET)
Applied DNA to Report First Quarter Fiscal 2024 Financial Results on Thursday, February 8, 2024
ACCESSWIRE (Mon, 5-Feb 1:01 PM ET)
ACCESSWIRE (Fri, 2-Feb 4:17 PM ET)
ACCESSWIRE (Wed, 31-Jan 8:00 AM ET)
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.
Applied Dna Sciences trades on the NASDAQ stock market under the symbol APDN.
As of April 24, 2024, APDN stock price declined to $0.24 with 867,101 million shares trading.
APDN has a beta of 1.72, meaning it tends to be more sensitive to market movements. APDN has a correlation of 0.06 to the broad based SPY ETF.
APDN has a market cap of $4.14 million. This is considered a Sub-Micro Cap stock.
Last quarter Applied Dna Sciences reported $891,164 in Revenue and -$.09 earnings per share. This beat revenue expectation by $111,164 and exceeded earnings estimates by $.22.
In the last 3 years, APDN stock traded as high as $8.10 and as low as $.22.
The top ETF exchange traded funds that APDN belongs to (by Net Assets): VXF.
APDN has underperformed the market in the last year with a price return of -76.7% while the SPY ETF gained +24.1%. APDN has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -61.8% and -38.8%, respectively, while the SPY returned +4.4% and -2.8%, respectively.
APDN support price is $.27 and resistance is $.31 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that APDN stock will trade within this expected range on the day.